PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1397104
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1397104
Infection Control Market size was valued at USD 50,237.9 Million in 2022, expanding at a CAGR of 6.7% from 2023 to 2030.
Healthcare-associated infections rank amid the leading causes of death worldwide, responsible for nearly 100,000 fatalities annually in the United States alone. The transmission of these infections is influenced by various factors, including the infection control measures, patient's immune system, and the presence of numerous infectious agents within healthcare facilities. Additionally, factors like patient age and prolonged stays in healthcare settings significantly contribute to HAI development.
The market is primarily stimulated by the increasing number of high-intensity infection prevention measures required for surgical procedures. This heightened emphasis on infection control is driven by its positive impact on clinical outcomes. The COVID-19 pandemic has further bolstered market growth, with surging demand for sterilization and disinfection in hospitals, clinics, pharmaceutical, and medical device companies. For instance, the U.S. alone witnessed a 60% increase in the production of sanitizer products during the pandemic, underscoring the growth potential for infection control products in the years ahead. The market is also benefiting from the rising trend of outsourcing sterilization services and the introduction of advanced sterilization solutions. Moreover, the increasing number of government initiatives aimed at ensuring effective infection prevention plays a substantial role in fostering market growth.
The Global Infection Control Market is segmented on the basis of Product Type, End use, Distribution Channel, and Region.
The market is divided into four categories based on Product Type: Disinfectors, Sterilization Equipment, Consumables and Others. In 2022, the consumables segment took the lead in the infection control market, contributing the largest share of revenue. This dominant position is attributed to the consistent use and relatively short lifespan of consumable products. Consumables play a vital role in disinfection, sterilization, and various control procedures, making them an indispensable component and thus, commanding a substantial share.
The market is divided into four categories based on end use: Hospitals, Medical Device Companies, Clinical Laboratories, and Pharmaceutical Laboratories. In terms of end-use, hospitals were the dominant segment in the infection control market, capturing the largest revenue share in 2022. This segment is expected to maintain the fastest compound annual growth rate (CAGR) throughout the forecast period. The prevalence of hospital-acquired infections (HAIs), often transmitted through respiratory or bloodborne pathogens, makes stringent control measures imperative. Consequently, hospitals and public health organizations are adopting highly efficient control systems. Research published in NCBI indicates that surgical sites account for an estimated 40% to 60% of hospital-acquired infections.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Companies in the Infection Control Market employ a range of strategies to maintain their competitiveness. First and foremost, they prioritize research and development to continuously innovate and enhance their infection control products and technologies. Collaborations with healthcare institutions, government agencies, and research organizations are common to ensure product efficacy and regulatory compliance. Additionally, they invest in educational initiatives to raise awareness and promote best practices in infection control. Marketing and branding efforts highlight the importance of infection prevention, leveraging the increased focus on healthcare safety post-pandemic. Moreover, companies expand their portfolios by introducing advanced disinfection and sterilization solutions, while also exploring new markets and geographies to capitalize on global opportunities.
In August 2021, Advanced Sterilization Products, a company under Fortive, introduced the STERRAD VELOCITY, a Biological Indicator as well as Process Challenge Device.